166 filings
Page 4 of 9
8-K/A
zeaq7y
28 Mar 19
Departure of Directors or Certain Officers
4:46pm
8-K
jif2whqqiq9j897vnq7
8 Mar 19
Other Events
9:00am
8-K
z0leou77i qg4e7e
26 Feb 19
Regulation FD Disclosure
9:10am
8-K
pd3rg9pj02h4 h13tckb
13 Feb 19
Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2018 Investor Update
7:30am
8-K
v6cqhw kw
24 Jan 19
Ironwood Pharmaceuticals Announces Board of Directors for Ironwood and Cyclerion, Effective Following Separation
8:30am
8-K
ue93b
7 Jan 19
Results of Operations and Financial Condition
8:30am
8-K
skkwlntn7h55pe37r21
4 Jan 19
Ironwood Pharmaceuticals Announces Chief Executive Officers to Lead Ironwood and Cyclerion, Effective Upon Upcoming Separation
4:49pm
8-K
m5dhmcq
3 Jan 19
Material Modifications to Rights of Security Holders
4:59pm
8-K
9dlku4rd jh
6 Nov 18
Ironwood Pharmaceuticals Provides Third Quarter 2018 Investor Update
8:13am
8-K
cpujhtftdeo6g
6 Aug 18
Ironwood Pharmaceuticals Provides Second Quarter 2018 Investor Update
8:20am
8-K
gysjcye osc8d5e2o
27 Jun 18
Cost Associated with Exit or Disposal Activities
9:15am
8-K
bwihr0s6v fxh
12 Jun 18
Departure of Directors or Certain Officers
12:00am
8-K
5ffefqd853dy4mzsb
1 Jun 18
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
qy4va5xvmypx9kd3u
1 May 18
Ironwood Pharmaceuticals Provides First Quarter 2018 Investor Update
8:15am
8-K
momien7s
15 Feb 18
Fourth Quarter and Full Year 2017 Investor Update
12:00am
8-K
m3k9wbtn33x9t
30 Jan 18
Cost Associated with Exit or Disposal Activities
12:00am
8-K
un0gq6s26szb
8 Jan 18
Results of Operations and Financial Condition
12:00am
8-K
wf5abs brjhh
28 Nov 17
Ironwood Pharmaceuticals Strengthens Executive Leadership Team
12:00am
8-K
0ny5418uonb lhlvv
2 Nov 17
Third Quarter 2017 Investor Update
12:00am
8-K
fbimj8oq m36silj8n
6 Sep 17
Ironwood Pharmaceuticals Announces Leadership Change
12:00am